Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Fromm

Showing results (101-110 of 187) with videos related to

Pageof 19
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 3, 2018
Dose adjustment of cisplatin, etoposide, and ifosfamide according to kidney function: a retrospective analysis and implications for medication safetyCarolin Grafe, Sabine Semrau, Alexander Hein, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|January 22, 2020
[Impact of Sedating Drugs on Falls Resulting Injuries Among People with Dementia in a Nursing Home Setting]Theresa Lippert, Renke Maas, Martin F Fromm, et al.
Pharmacogenetics and Genomics|July 19, 2006
Effect of SLCO1B1 polymorphism on induction of CYP3A4 by rifampicinMikko Niemi, Kari T Kivistö, Ulf Diczfalusy, et al.
Clinical Pharmacology and Therapeutics|March 6, 2004
Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimensOliver von Richter, Oliver Burk, Martin F Fromm, et al.
Clinical Pharmacology and Therapeutics|September 17, 2004
Impact of concentration and rate of intraluminal drug delivery on absorption and gut wall metabolism of verapamil in humansHartmut Glaeser, Siegfried Drescher, Ute Hofmann, et al.
Deutsches Arzteblatt International|July 22, 2025
Pseudo-Worsening of Kidney FunctionMartin F Fromm, Michael I Sponfeldner, Frank Dörje, et al.
Clinical Pharmacology and Therapeutics|August 16, 2024
New Biomarkers for Renal Transporter-Mediated Drug-Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in HumansArne Gessner, Jörg König, Pia Wenisch, et al.
Clinical Pharmacology and Therapeutics|August 4, 2023
A Metabolomic Analysis of Sensitivity and Specificity of 23 Previously Proposed Biomarkers for Renal Transporter-Mediated Drug-Drug InteractionsArne Gessner, Fabian Müller, Pia Wenisch, et al.
Circulation. Cardiovascular Genetics|June 21, 2011
Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placementDietmar Trenk, Willibald Hochholzer, Martin F Fromm, et al.
The American Journal of Pathology|November 10, 2012
Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanismsOliver Zolk, Rebecca Schnepf, Marc Muschler, et al.
Pageof 19

Showing results (101-110 of 187) with videos related to

Sort By:
Pageof 19
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 3, 2018
Dose adjustment of cisplatin, etoposide, and ifosfamide according to kidney function: a retrospective analysis and implications for medication safetyCarolin Grafe, Sabine Semrau, Alexander Hein, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|January 22, 2020
[Impact of Sedating Drugs on Falls Resulting Injuries Among People with Dementia in a Nursing Home Setting]Theresa Lippert, Renke Maas, Martin F Fromm, et al.
Pharmacogenetics and Genomics|July 19, 2006
Effect of SLCO1B1 polymorphism on induction of CYP3A4 by rifampicinMikko Niemi, Kari T Kivistö, Ulf Diczfalusy, et al.
Clinical Pharmacology and Therapeutics|March 6, 2004
Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimensOliver von Richter, Oliver Burk, Martin F Fromm, et al.
Clinical Pharmacology and Therapeutics|September 17, 2004
Impact of concentration and rate of intraluminal drug delivery on absorption and gut wall metabolism of verapamil in humansHartmut Glaeser, Siegfried Drescher, Ute Hofmann, et al.
Deutsches Arzteblatt International|July 22, 2025
Pseudo-Worsening of Kidney FunctionMartin F Fromm, Michael I Sponfeldner, Frank Dörje, et al.
Clinical Pharmacology and Therapeutics|August 16, 2024
New Biomarkers for Renal Transporter-Mediated Drug-Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in HumansArne Gessner, Jörg König, Pia Wenisch, et al.
Clinical Pharmacology and Therapeutics|August 4, 2023
A Metabolomic Analysis of Sensitivity and Specificity of 23 Previously Proposed Biomarkers for Renal Transporter-Mediated Drug-Drug InteractionsArne Gessner, Fabian Müller, Pia Wenisch, et al.
Circulation. Cardiovascular Genetics|June 21, 2011
Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placementDietmar Trenk, Willibald Hochholzer, Martin F Fromm, et al.
The American Journal of Pathology|November 10, 2012
Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanismsOliver Zolk, Rebecca Schnepf, Marc Muschler, et al.
Pageof 19